Delivery Order SPE2DR25D3103-SPE2DR26F9V62
- Not listed
- The Defense Logistics Agency awarded a $1,196.02 firm fixed-price delivery order to Amerisourcebergen Drug Corp on January 7, 2026, for the supply of Lyrica 75 mg capsules (90 count). This non-set-aside contract represents a delivery order under Amerisourcebergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The product will be delivered to the company's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $3,322.15 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Lyrica 75 mg capsules in unit dose packaging (100 count) on December 18, 2025, with completion scheduled for December 19, 2025. This non-competitive delivery order represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The prime contractor, headquartered in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 30, 2025, for the supply of Lyrica 150 mg capsules (90-count units) valued at $1,723.91. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The order is scheduled for completion by December 31, 2025, and will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,144.62 to AmerisourceBergen Drug Corp for the supply of Lyrica 75 mg capsules (90-count units) on November 24, 2025, with a completion date of November 25, 2025. This non-competitive, firm fixed-price delivery order will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $3,119.78 to AmerisourceBergen Drug Corp for the supply of Lyrica 100 mg capsules (90-count units) on December 16, 2025, with completion expected by December 17, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and will be performed at the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, holds...
- The Defense Logistics Agency awarded a $2,336.03 delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Lyrica 100 mg capsules (90-count units). This competitively awarded contract utilizes firm fixed pricing and is classified as a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The product will be delivered to AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Lyrica 75 mg capsules (90-count units) under a firm fixed-price contract valued at $4,977.56, with a completion date of December 30, 2025. This non-set-aside award was competitively procured and represents a single delivery order from AmerisourceBergen's broader relationship with the federal government. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major...
- The Defense Logistics Agency awarded a $3,551.28 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Lyrica 200 mg capsules (90-count units) on August 22, 2025, with an ultimate completion date of August 25, 2025. This non-competitive delivery order represents a routine pharmaceutical procurement under the company's existing contract vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor...
- The Defense Logistics Agency awarded a delivery order valued at $2,279.00 to AmerisourceBergen Drug Corp for Lyrica 25 mg capsules (90-count) on November 17, 2025, with completion targeted for November 18, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the Conshohocken, Pennsylvania-based pharmaceutical distributor. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken. This delivery order is issued...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,580.34 to AmerisourceBergen Drug Corp for the supply of Lyrica 100 mg capsules (90-count units). This firm fixed price, competitively awarded contract was issued on September 11, 2025, with an ultimate completion date of September 12, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting open competition among qualified pharmaceutical...
- SPE2DR25D3103Indefinite Delivery Contract
- SPE2DR25D3103-SPE2DR26F9V62Delivery Order
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $1,196.02 to AmerisourceBergen Drug Corp for the supply of Lyrica 75 mg capsules (90-count units). The contract, awarded on January 8, 2026, with an ultimate completion date of January 9, 2026, represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor on this order. The company is a subsidiary of Cencora, Inc., a major pharmaceutical distributor specializing in providing comprehensive pharmaceutical products and medical supplies to federal government agencies, particularly those supporting military and veteran healthcare systems. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 through December 2026. This comprehensive IDC serves as a global pharmaceutical support vehicle enabling the delivery of a broad range of pharmaceutical products, generic and brand-name medications, vaccines, and specialized medical supplies across multiple therapeutic domains to support military healthcare programs worldwide. Lyrica, a neurological treatment medication, exemplifies the specialized pharmaceutical commodities routinely procured through this vehicle to meet the medical needs of the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 1/7/26 |